Global platform-based biopharmaceutical company discovering and developing antibody therapeutics, with proprietary transgenic mouse, single B-cell cloning, bispecific and multispecific antibody platforms and AI-enabled antibody discovery
Global platform-based biopharmaceutical company discovering and developing antibody therapeutics, with proprietary transgenic mouse, single B-cell cloning, bispecific and multispecific antibody platforms and AI-enabled antibody discovery. Its therapeutic focus includes oncology, immunology, neuroscience, and metabolic diseases; it also develops and partners on clinical-stage medicines.